All Stories

  1. The Role of Statins on Helicobacter pylori Eradication: Results from the European Registry on the Management of H. pylori (Hp-EuReg)
  2. European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice
  3. European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain
  4. Celiac Disease: A Common Unrecognized Health Problem with a Very Delayed Diagnosis
  5. The effect of Betanin parenteral pretreatment on Jejunal and pulmonary tissue histological architecture and inflammatory response after Jejunal ischemia-reperfusion injury
  6. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma
  7. Eosinophilic esophagitis: An evidenced-based approach to diagnosis and treatment
  8. Esofagitis eosinofílica: aproximación al diagnóstico y tratamiento desde la evidencia
  9. The role of dietary phytochemicals in the carcinogenesis via the modulation of miRNA expression
  10. Markers of Atherosclerosis: Part 1 – Serological Markers
  11. Markers of Atherosclerosis: Part 2 – Genetic and Imaging Markers
  12. Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment
  13. Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic review
  14. Impact of drugs on venous thromboembolism risk in surgical patients
  15. Descriptive Study of the Different Tools Used to Evaluate the Adherence to a Gluten-Free Diet in Celiac Disease Patients
  16. Evaluation of Efficacy and Adherence to Gluten-Free Diet in Patients with Celiac Disease
  17. Cutaneous and Mucosal Manifestations Associated with Celiac Disease
  18. Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma
  19. Cutaneous and Mucosal Manifestations Associated to Celiac Disease
  20. Efficacy of a Gluten-Free Diet in the Gilles de la Tourette Syndrome: A Pilot Study
  21. Novel inflammatory biomarkers
  22. Efficacy of a Gluten-Free Diet in the Gilles de la Tourette Syndrome: A Pilot Study
  23. Faecal Calprotectin
  24. Therapeutical strategies for anxiety and anxiety-like disorders using plant-derived natural compounds and plant extracts
  25. Quercetin attenuates the ischemia reperfusion induced COX-2 and MPO expression in the small intestine mucosa
  26. Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women
  27. Inducible nitric oxide synthase: Good or bad?
  28. Celiac Disease and Non-Celiac Gluten Sensitivity
  29. Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats
  30. Nitric oxide in the pathophysiology of retinopathy: evidences from preclinical and clinical researches
  31. Effects of polyphenol compounds melanin on NAFLD/NASH prevention
  32. Cyp2c19 Genotype and Response to Proton Pump Inhibitor Therapy in Naãÿve Adult Patients with Eosinophilic Esophagitis
  33. Association between psychological measures with inflammatory anddisease-related markers of inflammatory bowel disease
  34. Downregulation of myogenic microRNAs in sub-chronic but not in sub-acute model of daunorubicin-induced cardiomyopathy
  35. Human Helminthiasis
  36. Nanocrystalline cerium dioxide efficacy for prophylaxis of erosive and ulcerative lesions in the gastric mucosa of rats induced by stress
  37. Chili pepper as a body weight-loss food
  38. Perspectives and challenges of antioxidant therapy for atrial fibrillation
  39. Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade
  40. Colorectal Cancer - From Pathogenesis to Treatment
  41. Erratum to: Biosensors for the Diagnosis of Celiac Disease: Current Status and Future Perspectives
  42. Effect of Low Dose Atorvastatin Therapy on Baroreflex Sensitivity in Hypertensives
  43. Biosensors for the Diagnosis of Celiac Disease: Current Status and Future Perspectives
  44. Tu1335 European Registry on H. pylori Management (HP-EuReg) in Spain: Interim Analysis in First and Second Line Therapies
  45. Gluten ataxia is better classified as non-celiac gluten sensitivity than as celiac disease: a comparative clinical study
  46. Protective effect of ischemic preconditioning on the jejunal graft mucosa injury during cold preservation
  47. Epidemiology of Celiac Disease and Non-Celiac Gluten-Related Disorders
  48. Extraintestinal Manifestations of Celiac Disease and Associated Disorders
  49. The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in patients with dyslipoproteinemia and comparison with plasma atherogenicity indicators—A pilot study
  50. P0521 : Characterization and validation of angiogenic genetic variants related to chronic hepatitis C progression to hepatocellular carcinoma
  51. The impact of thyroid hormone replacement therapy on left ventricular diastolic function in patients with subclinical hypothyroidism
  52. Etiology of Pancreatitis and Risk Factors
  53. Acute and Chronic Pancreatitis
  54. Anaemia due to gastric haemorrhage by a metastatic Merkel cell carcinoma
  55. Celiac Disease and Non-Celiac Gluten Sensitivity
  56. Celiac Disease and Non-Celiac Gluten Sensitivity
  57. Extraintestinal Manifestations and Associated Diseases
  58. Effect of one year of a gluten-free diet on the clinical evolution of irritable bowel syndrome plus fibromyalgia in patients with associated lymphocytic enteritis: a case-control study
  59. Su1167 European Registry on H. pylori Management (Hp-EuReg): Spanish Detailed Results (Interim Analysis)
  60. Comments on ‘Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia’ by Vanheelet al
  61. P773 ANGIOGENIC BIOMARKERS OF CHRONIC HEPATITIS C PROGRESSION TO HEPATOCELLULAR CARCINOMA
  62. P219 FINE MAPPING OF THE BUTYROPHILIN GENOMICS REGION: ROLE IN HEPATITIS C VIRUS INFECTION (HCV)
  63. Autoantibodies against MHC class I polypeptide-related sequence A are associated with increased risk of concomitant autoimmune diseases in celiac patients
  64. Response to ‘Remarkable prevalence of celiac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study’ – authors’ reply
  65. Transcultural adaptation and validation of the Celiac Disease Quality of Life (CD-QOL) survey, a specific questionnaire to measure quality of life in patients with celiac disease
  66. Clinical impact of a gluten-free diet on health-related quality of life in seven fibromyalgia syndrome patients with associated celiac disease
  67. Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection
  68. Regulation of NKG2D signaling during the epithelial-to-mesenchymal transition
  69. Manifestaciones extra-intestinales y enfermedades asociadas
  70. Enfermedad celíaca y sensibilidad al gluten no celíaca
  71. Enfermedad celíaca y sensibilidad al gluten no celíaca
  72. 854 POLYMORPHISMS IN HISTONE DEACETYLASES IMPROVE THE PREDICTIVE VALUE OF IL-28B FOR CHRONIC HEPATITIS C THERAPY
  73. Urticaria pigmentosa in a female patient with celiac disease: Response to a gluten-free diet
  74. Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection
  75. Annual Incidence of Hepatocellular Carcinoma Among Patients With Alcoholic Cirrhosis and Identification of Risk Groups
  76. Celiac Disease and Autoimmune-Associated Conditions
  77. Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study
  78. Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal Tumors
  79. Situación actual del manejo de la hemorragia digestiva alta no varicosa en España
  80. Multiple Sclerosis and Celiac Disease
  81. A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping
  82. 924 A GENOME-WIDE ASSOCIATION STUDY IDENTIFIED A NOVEL SUSCEPTIBILITY LOCUS GENE PBK (RS 17388536)FOR SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS BEARING IL28B GENOTYPE CC
  83. 908 FACTORS INVOLVED IN SUSTAINED VIRAL RESPONSE (SVR) ACHIEVEMENT IN PATIENTS WITH FAVORABLE IL28B CC GENOTYPE IN HEPATITIS C
  84. 904 HOST GENETIC VARIANTS IN INTERFERON SIGNALING PATHWAY RELATED TO NECROINFLAMMATORY ACTIVITY IN CHRONIC HEPATITIS C
  85. 923 INTERACTION BETWEEN RS12979860 POLYMORHISM OF IL28B GENE WITH BASELINE PREDICTIVE FACTORS OF RESPONSE TO TREATMENT IN PATIENTS WITH HEPATITIS C
  86. Pancreatitis - Treatment and Complications
  87. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures
  88. Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration
  89. Acute Pancreatitis
  90. Osteogenesis Imperfecta with Celiac Disease and Type II Diabetes Mellitus Associated: Improvement with a Gluten-Free Diet
  91. Porphyria cutanea tarda with multiple nodular foci in the liver
  92. Usefulness of an Intensive Bowel Cleansing Strategy for Repeat Colonoscopy After Preparation Failure
  93. Refractory iron-deficiency anemia and gluten intolerance: Response to gluten-free diet
  94. Fourth-Line Rescue Therapy With Rifabutin in Patients With Three H. pylori Eradication Failures
  95. Helicobacter pylori Levofloxacin-Based Rescue Option in Patients Allergic to Penicillin Failing a Previous Treatment With Clarithromycin and Metronidazole
  96. Performance of Two Interferon-Gamma Release Assays (T-SPOT.TB and QuantiFERON-TB Gold in Tube) Increase Diagnostic Yield of Tuberculin Skin Testing for Detection of Latent Tuberculosis in Patients With Inflammatory Bowel Disease
  97. Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure. Time Trends of Eradication in a Spanish Multicenter Study of 830 Patients
  98. Safety of Immunomodulators and Anti-TNF Drugs for the Treatment of Inflammatory Bowel Disease (IBD) During Pregnancy
  99. Prevalence of celiac disease in multiple sclerosis
  100. 461 ACUTE HEPATITIS C IN SPAIN. RETROSPECTIVE STUDY OF 131 PATIENTS
  101. 1162 ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN INTERFERON STIMULATED GENES WITH CHRONIC HEPATITIS C TREATMENT OUTCOME
  102. NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system
  103. Coeliac Disease in the 21st Century: No Longer “Kids’ Stuff”
  104. Endoscopic resection techniques and ablative therapies for Barrett’s neoplasia
  105. Neurogluten: patología neurológica por intolerancia al gluten
  106. Association of FcgR2a, but not FcgR3a, with inflammatory bowel diseases across three Caucasian populations†
  107. Acute and chronic effect of copper on levels of reduced and oxidized glutathione and nutrient uptake of tomato plants
  108. Kaposi's sarcoma: An opportunistic infection by human herpesvirus-8 in ulcerative colitis
  109. Síndrome de Down y enfermedad celíaca del adulto asociadas: estudio de 9 casos
  110. Adult Patients with Eosinophilic Esophagitis Do Not Show an Increased Frequency of the HLA-DQ2/DQ8 Genotypes Predisposing to Celiac Disease
  111. Adult celiac disease: a common, significant health problem worldwide
  112. Respuesta
  113. Gluten sensitivity and the CNS: diagnosis and treatment
  114. Síndrome de Turner y enfermedad celíaca del adulto
  115. STAT4 gene influences genetic predisposition to ulcerative colitis but not Crohn's disease in the Spanish population: A replication study
  116. S1396: An Intensive Bowel Cleansing Strategy for Patients With Previous Colonoscopy Preparation Failure: Results of a Prospective Study
  117. T1610: Gastric Endoscopic Submucosal Dissection (ESD) With the Aid of a New Traction Method, the Clip-Band Technique: A Feasibility Study in a Porcine Model
  118. Sp271: Gastric Endoscopic Submucosal Dissection (ESD) with a New Traction Method: The Clip-Band Technique
  119. ITER operating limit definition criteria
  120. Infliximab Maintenance Therapy Is Associated With Decreases in Direct Resource Use in Patients With Luminal or Fistulizing Crohnʼs Disease
  121. CD8dim and NKG2D Expression Defines Related Subsets of CD4+ T cells in HIV-Infected Patients With Worse Prognostic Factors
  122. Tuberculosis peritoneal por Mycobacterium bovis en paciente cirrótico
  123. Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice
  124. Respuesta de los autores
  125. Prevalence of antibody to hepatitis C virus in prospectively followed acute non-A, non-B hepatitis, from different epidemiological categories
  126. Enfermedad celíaca
  127. Enfermedad celíaca
  128. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility
  129. Comparative effectiveness of azathioprine in Crohn’s disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients
  130. Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing–remitting multiple sclerosis
  131. Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients
  132. Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C
  133. Sustained improvement of health-related quality of life in Crohnʼs disease patients treated with infliximab and azathioprine for 4 years
  134. The allele MICB*0050204, over-represented in the Caucasian population, has an additional exon resulting from a new splice junction sequence
  135. Transcriptional regulation of MICA and MICB: A novel polymorphism in MICB promoter alters transcriptional regulation by Sp1
  136. [558] ASSESSMENT OF FIBROSIS DISTRIBUTION IN PATIENTS WITH CHRONIC HEPATITIS C USING COMPUTER-PERFORMED OPTICAL ANALYSIS OF CT OF THE LIVER (FibroCT®)
  137. Association of killer immunoglobulin-like receptors and their HLA Class I ligands with progression of chronic hepatitis C virus infection
  138. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations
  139. Thiopurine Methyltransferase (TPMT) Activity and Adverse Effects of Azathioprine in Inflammatory Bowel Disease: Long-Term Follow-Up Study of 394 Patients
  140. Effect of defunctionalization on colon carcinogenesis in the rat
  141. Lower GI bleeding secondary to a stromal rectal tumor (rectal GIST)
  142. 93 Amoxicillin-clavulanate (AC) associated hepatotoxicity: Analysis of a single country large cohort prospectively identified
  143. 669 Chronic liver damage after an episode of idiosyncratic drug induced liver injury (DILI)
  144. MHC Class I Chain-Related Gene B Promoter Polymorphisms and Celiac Disease
  145. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry
  146. Celiac disease
  147. Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response
  148. Usefulness of duodenal biopsy during routine upper gastrointestinal endoscopy for diagnosis of celiac disease
  149. A Nationwide Study of Mortality Associated with Hospital Admission Due to Severe Gastrointestinal Events and Those Associated with Nonsteroidal Antiinflammatory Drug Use
  150. Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period
  151. Protective Effect of the HLA‐Bw4I80 Epitope and the Killer Cell Immunoglobulin‐Like Receptor 3DS1 Gene against the Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection
  152. Use of Low Concentrations of Human IgA Anti-Tissue Transglutaminase to Rule Out Selective IgA Deficiency in Patients with Suspected Celiac Disease,
  153. Impairment of Health-Related Quality of Life in Patients With Inflammatory Bowel Disease: a Spanish Multicenter Study
  154. Association of Helicobacter pylori-related Distal Gastric Cancer with the HLA Class II Gene DQB1*0602 and cagA+ Strains in a Southern European Population
  155. Diverse clinical presentations of celiac disease in the same family
  156. Infliximab improves quality of life in the short-term in patients with fistulizing Crohn's disease in clinical practice
  157. A population-based study on the incidence of inflammatory bowel disease in Oviedo (Northern Spain)
  158. Response to Dr. Bogdanos
  159. MHC Class I Region Plays a Role in the Development of Diverse Clinical forms of Celiac Disease in a Saharawi Population
  160. Severe toxic hepatitis related to chlormethiazole
  161. Overview of JET results
  162. Comparative study of the efficacy of an induction dose of interferon-alpha2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C
  163. MHC class I chain-related gene A transmembrane polymorphism modulates the extension of ulcerative colitis
  164. TNF-$alpha; $minus;308A promoter polymorphism is associated with enhanced TNF-$alpha; production and inflammatory activity in Crohn?s patients with fistulizing disease
  165. Extended HLA haplotype EH18. 1 influences the progression to hepatocellular carcinoma in patients with hepatitis C virus infection
  166. HLA class II molecules and drug-induced idiosyncratic liver disease. A multicenter study
  167. Levosulpiride in the treatment of dysmotility-like functional dyspepsia: Randomised double-dimmed comparison with cisapride
  168. MHC class I chain-like gene A (MICA) trinucleotide repeat polymorphism is associated with disease susceptibility and behavior in ulcerative colitis
  169. Retreatment and maintenance therapy with infliximab in fistulising Crohn's disease
  170. MICB typing by PCR amplification with sequence specific primers
  171. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
  172. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis
  173. Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results
  174. Cognitive Deficits in Patients With Hepatic Cirrhosis and in Liver Transplant Recipients
  175. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial
  176. Low Frequency of Upper Gastrointestinal Complications in a Cohort of High-Risk Patients Taking Low-Dose Aspirin or NSAIDS and Omeprazole
  177. Celiac disease in autoimmune cholestatic liver disorders
  178. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease
  179. High serum tumor necrosis factor-α levels are associated with lack of response to infliximab in fistulizing Crohn's disease
  180. Autoantibodies to Golgi proteins in hepatocellular carcinoma: case report and literature review
  181. Acute Hepatitis Associated With Cetirizine Intake
  182. MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201
  183. Current concepts in the management of Helicobacter pylori infection-The Maastricht 2-2000 Consensus Report
  184. MICA-A5.1 allele is associated with atypical forms of celiac disease in HLA-DQ2-negative patients
  185. The relationship of overweight and obesity with subjective health and use of health-care services among Spanish women
  186. Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders
  187. Nimesulide-Induced Severe Hemolytic Anemia and Acute Liver Failure Leading to Liver Transplantation
  188. Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine
  189. Clinical efficacy of the Toupet technique performed by laparoscopic surgery
  190. Nodular Regenerative Hyperplasia of the Liver in a Patient With Celiac Disease
  191. Riluzole-induced acute pancreatitis
  192. Antilactoferrin antibodies in autoimmune liver disease
  193. Prevalence of hepatitis C virus infection in the general population of northern Spain
  194. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia
  195. Hepatitis aguda por ticlopidina. Presentación de 12 casos y revisión de la literatura
  196. Letters to the Editor
  197. Diagnostic value of adenosine deaminase isoenzymes in ascitic fluid
  198. Aging characteristics of Zr–V–Fe getters as observed by Mössbauer spectroscopy
  199. N-Acetyltransferase-2, Glutathione S-Transferase M1, Alcohol Dehydrogenase, and Cytochrome P450IIE1 Genotypes in Alcoholic Liver Cirrhosis: A Case?Control Study
  200. Tamoxifen Does Not Improve Survival of Patients With Advanced Hepatocellular Carcinoma
  201. Clinical efficacy and safety of pantoprazole versus ranitidine in patients with acute duodenal ulcer: Spanish multicenter study
  202. Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial
  203. Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer
  204. Characterization of Deactivated Metal Getters Used in a Glove Box Purification System
  205. Characterization of Tritiated Hydrocarbon Species and Measurement of Their Concentrations in Air during Vacuum Pump Maintenance
  206. Experimental Demonstration of the HITEX Process for Fusion Fuel Clean-Up
  207. Measurement of Tritium on Surfaces
  208. First Results of the TJ-I U Torsatron
  209. Clinical efficacy of intramuscular human interferon-β vs interferon-α2b for the treatment of chronic hepatitis C
  210. Tuberculous Peritonitis: Diagnostic Value of Ascitic Fluid pH and Lactate
  211. Acute exacerbations in chronic HBsAg carriers: is HCV implicated?
  212. Limitations of serological assays for hepatitis C virus screening in blood donors
  213. Pneumopericardium without subcutaneous emphysema, pneumomediastinum, or pneumothorax after laparoscopy
  214. Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C.
  215. Treatment of chronic hepatitis C with recombinant interferon alfa-2b for nine months.
  216. Hepatitis C virus infection in patients with acute hepatitis B
  217. Tritium Measurement and Monitoring in Experimental and Process Systems with Ionization Chambers
  218. Second-Generation Tests for Hepatitis C Virus
  219. Intrafamilial spread of hepatitis C virus
  220. Unusual foreign body protruding into the duodenum
  221. Hepatitis Delta Virus Infection and Acute HBsAg-Negative Hepatitis B
  222. Serum and bile modifications in the guinea-pig following chronic treatment with PGE1 and PGE2
  223. Diet and Colon Cancer
  224. Hereditary hemochromatosis